bmy 7378 has been researched along with sdz 216-525 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fozard, JR; Hoyer, D; McQuade, R; Sharp, T | 1 |
| Ennis, C; Khawaja, X; Minchin, MC | 1 |
2 other study(ies) available for bmy 7378 and sdz 216-525
| Article | Year |
|---|---|
The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Dialysis; Electrophysiology; GTP-Binding Proteins; Hippocampus; Indoles; Male; Neurons; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Thiazoles | 1993 |
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; CHO Cells; Cricetinae; Hippocampus; Humans; In Vitro Techniques; Kinetics; Piperazines; Pyridines; Radioligand Assay; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1997 |